Europe

Coronavirus: Spanish study casts doubt on herd immunity feasibility

A Spanish Civil Guard controls a checkpoint on the highway between the regions of Galicia and Asturias in Ribadeo on July 6, 2020 Image copyright AFP
Image caption The study estimates that around just 5% of the Spanish population has developed antibodies

A Spanish study has cast doubt on the feasibility of herd immunity as a way of tackling the coronavirus pandemic.

The study of more than 60,000 people estimates that around just 5% of the Spanish population has developed antibodies, the medical journal the Lancet reported.

Herd immunity is achieved when enough people become immune to a virus to stop its spread.

Around 70% to 90% of a population needs to be immune to protect the uninfected.

The prevalence of Covid-19 antibodies was below 3% in coastal regions, but higher in areas of Spain with widespread outbreaks, the report said.

"Despite the high impact of Covid-19 in Spain, prevalence estimates remain low and are clearly insufficient to provide herd immunity," the study's authors said in the report.

"This cannot be achieved without accepting the collateral damage of many deaths in the susceptible population and overburdening of health systems.

"In this situation, social distance measures and efforts to identify and isolate new cases and their contacts are imperative for future epidemic control."

The study is thought to be the largest of its kind on the coronavirus in Europe.

There have been studies of a similar kind in China and the US and "the key finding from these representative cohorts is that most of the population appears to have remained unexposed" to the coronavirus, "even in areas with widespread virus circulation," the Lancet article said.

Prof Danny Altmann, British Society for Immunology spokesperson and Professor of Immunology at Imperial College London, described the study as "sobering".

"Findings such as this reinforce the idea that faced with a lethal infection that induces rather short-lived immunity, the challenge is to identify the best vaccine strategies able to overcome these problems and stimulate a large, sustained, optimal, immune response in the way the virus failed to do," Prof Altmann said.

What's the latest in Spain?

The country has recorded more than a quarter of a million cases and at least 28,385 deaths. But daily fatalities have been in the single figures for most of the past three weeks.

However, officials in the north-western region of Galicia have re-imposed restrictions on an area of 70,000 people following an outbreak.

Officials linked local outbreaks to bars in the area. Capacity in bars and restaurants have been limited to 50%.

There are now 258 cases of Covid-19 in Galicia, including 117 in Lugo province, authorities say.

On Saturday the autonomous government of Catalonia re-imposed controls on an area of 210,000 residents after a sharp rise in infections there.

Catalan President Quim Torra said no-one would be allowed to enter or leave SegriĆ , a district west of Barcelona that includes the city of Lleida.

The search for a fit response

Herd immunity can be reached either by widespread vaccination or if enough of the population is exposed to an infection and recovers. If enough people are immune to a disease, it is unlikely to keep spreading from person to person. Letting the coronavirus infection run and risking lots of people getting very sick with it is not an option - it would put too many lives in danger.

And currently, there is no vaccine for coronavirus - even though hundreds are in development. The challenge is to make a jab that provides enough protection. It needs to train the body's immune system to learn and remember how to make antibodies that can fight off coronavirus.

Scientists are concerned that this "memory" might be too short-lived though, given the nature of the disease. While some people who catch coronavirus develop protective antibodies, experts do not yet know how long these last.

Common colds are caused by similar viruses and the body's immune response fades quickly to those.

Media playback is unsupported on your device
Media captionHow vaccines and herd immunity works

More on this story